G01N 2333/605
Glucagons
G01N2333/605 (Glucagons) appears on 43 US grants and 63 published applications in this corpus.
Search patents in G01N- Granted patents
- 43
- Published applications
- 63
- Assignees
- 37
- Inventors
- 98
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 2 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 3 |
| 2012 | 1 | 5 |
| 2013 | 2 | 3 |
| 2014 | 6 | 7 |
| 2015 | 3 | 2 |
| 2016 | 2 | 3 |
| 2017 | 2 | 5 |
| 2018 | 0 | 1 |
| 2019 | 3 | 8 |
| 2020 | 5 | 4 |
| 2021 | 0 | 3 |
| 2022 | 4 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 3 |
| 2025 | 0 | 3 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions relating to microbial treatment and diagnosis of disorders10 Feb 2026US 12,544,412 B2Pendulum Therapeutics, Inc.
- Methods and compositions relating to microbial treatment and diagnosis of disorders19 Mar 2024US 11,931,387 B2Pendulum Therapeutics, Inc.
- Methods and systems for detecting peptide aggregates26 Dec 2023US 11,851,487 B2
- Methods and compositions relating to microbial treatment and diagnosis of disorders21 Jun 2022US 11,364,270 B2Pendulum Therapeutics, Inc.
- Method for screening for diabetes mellitus therapeutic agents26 Apr 2022US 11,311,497 B2University—Industry Corporation Group of Kyung Hee University
- Carry-over free method for semaglutide quantitation25 Jun 2026US 2026/0177555 A1Shimadzu Corporation
- Compounds useful to treat metabolic disorders13 Nov 2025US 2025/0346646 A1President and Fellows of Harvard College
- Methods for detecting metabolic markers11 Sep 2025US 2025/0283891 A1Cedars-Sinai Medical Center
- Methods for Sample Quality Assessment13 Feb 2025US 2025/0052766 A1SomaLogic Operating Co., Inc.
- Methods and systems for detecting peptide aggregates14 Nov 2024US 2024/0376192 A1Rensselaer Polytechnic Institute
Most cited
By later US patents
- Glucagon-like peptide-2 and its therapeutic use80US 5,990,077 A1149336 Ontario Inc. · 1999
- Mammalian receptors for glucagon-like-peptide-1 (GLP-1), corresponding DNA and recombinant expression systems, and screening assays for GLP-1 agonists and enhancers57US 5,670,360 ANovo Nordisk A/S · 1997
- Receptor for the glucagon-like-peptide (GLP-1)52US 6,051,689 ANovo Nordisk A/S · 2000
- Method for detecting glucagon-like peptide-1 antagonists and agonists51US 5,846,747 ANovo Nordisk A/S · 1998
- Glucagon receptor proteins, peptides, and antibodies30US 5,770,445 AZymoGenetics, Inc. · 1998